Gill Karminder S, Yankaskas Bonnie C
Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
Cancer. 2004 Jan 1;100(1):139-48. doi: 10.1002/cncr.11878.
Despite improvement in mammography screening attendance, black women continue to have poorer prognosis at diagnosis than white woman. Data from the Carolina Mammography Registry were used to evaluate whether there may be differences in mammography performance or detected cancers when comparing black women with white women who are screened by mammography.
Prospectively collected data from community-based mammography facilities on 468,484 screening mammograms (79,397 in black women and 389,087 in white women) were included for study. Mammograms were linked to a pathology data base for identification of cancers. Sensitivity, specificity, positive predictive value, and cancer detection rates were compared between black women and white women. Logistic regression methods were used to control for covariates associated with performance characteristics. Differences in cancer characteristics were compared between black women and white women using chi-square statistics.
Screening mammography performance results for black women compared with white women were as follows: sensitivity, odds ratio (OR) = 1.07 (95% confidence interval [95% CI], 0.83-1.39); specificity, OR = 1.02 (95% CI, 0.98-1.06); and positive predictive value, OR = 1.07 (95% CI, 0.94-1.23). Among women with no previous screening, black women had a larger proportion of invasive tumors that measured > or = 2 cm (38% vs. 26%; P = 0.04). The cancer detection rate was highest among black women who reported symptoms at screening (13.9 per 1000 black women vs. 7.9 per 1000 white women). Invasive cancers in black women were poorer grade (P = 0.001), and more often had negative estrogen receptor status and progesterone receptor status (P < 0.001).
Overall, screening mammography performed equally well in black women and white women controlling for age, breast density, and time since previous mammogram. Black women who reported symptoms had larger and higher grade tumors compared with white women. Educational efforts need to be strengthened to encourage black women to react sooner to symptoms, so that the tumors detected will be smaller and black women will have a better prognosis when they appear for mammography.
尽管乳腺钼靶筛查的参与率有所提高,但黑人女性在诊断时的预后仍比白人女性差。利用卡罗来纳乳腺钼靶登记处的数据,评估在比较接受乳腺钼靶筛查的黑人女性和白人女性时,乳腺钼靶检查的表现或检测到的癌症是否存在差异。
纳入前瞻性收集的来自社区乳腺钼靶检查机构的468484例筛查乳腺钼靶检查数据(黑人女性79397例,白人女性389087例)进行研究。乳腺钼靶检查结果与病理数据库关联以识别癌症。比较黑人女性和白人女性之间的敏感性、特异性、阳性预测值和癌症检出率。采用逻辑回归方法控制与检查表现特征相关的协变量。使用卡方统计比较黑人女性和白人女性之间癌症特征的差异。
黑人女性与白人女性乳腺钼靶筛查表现结果如下:敏感性,比值比(OR)=1.07(95%置信区间[95%CI],0.83 - 1.39);特异性,OR =1.02(95%CI,0.98 - 1.06);阳性预测值,OR =1.07(95%CI,0.94 - 1.23)。在既往未接受过筛查的女性中,黑人女性中直径≥2 cm的浸润性肿瘤比例更高(38%对26%;P =0.04)。在筛查时有症状报告的黑人女性中癌症检出率最高(每1000名黑人女性中有13.9例 vs. 每1000名白人女性中有7.9例)。黑人女性的浸润性癌症分级较差(P =0.001),且雌激素受体和孕激素受体状态为阴性的情况更常见(P <0.001)。
总体而言,在控制年龄、乳腺密度和上次乳腺钼靶检查后的时间等因素后,黑人女性和白人女性的乳腺钼靶筛查表现相当。与白人女性相比,有症状报告的黑人女性肿瘤更大且分级更高。需要加强教育工作,鼓励黑人女性更早对症状做出反应,以便检测到的肿瘤更小,黑人女性在进行乳腺钼靶检查时预后更好。